Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children.

[1]  J. Eskola,et al.  Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. , 2000, Vaccine.

[2]  N. Begg,et al.  Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine , 1999, Epidemiology and Infection.

[3]  J. Eskola,et al.  Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies. , 1999, The Pediatric infectious disease journal.

[4]  J. Deeks,et al.  Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. , 1999, Vaccine.

[5]  T. Kurata,et al.  IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. , 1998, Vaccine.

[6]  J. Eskola,et al.  Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. , 1998, Vaccine.

[7]  R. Malley,et al.  Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats. , 1998, The Journal of infectious diseases.

[8]  Saarinen,et al.  Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines , 1998, Clinical and experimental immunology.

[9]  D. Greenberg,et al.  Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. , 1996, The Journal of infectious diseases.

[10]  S. Obaro,et al.  Carriage of pneumococci after pneumococcal vaccination , 1996, The Lancet.

[11]  M. Kilian,et al.  Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence * , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  J. Eskola,et al.  Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. , 1995, The Pediatric infectious disease journal.

[13]  B. Greenwood,et al.  A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. , 1995, The Journal of infectious diseases.

[14]  C. Frasch,et al.  Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays , 1994, Journal of bacteriology.

[15]  B. Plikaytis,et al.  Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. , 1993, The Journal of infectious diseases.

[16]  H. Käyhty,et al.  Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. , 1993, The Journal of infectious diseases.

[17]  B. Plikaytis,et al.  Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay , 1992, Journal of clinical microbiology.

[18]  J. Ekstrand,et al.  Humoral immunity in root caries in an elderly population. II..: Collection, processing, preservation of antibody activity and influence of diurnal and monthly variation on collection procedures , 1990 .

[19]  J. Mcghee,et al.  Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. , 1990, Journal of immunology.

[20]  C. Adamsbaum,et al.  AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINE , 1985, The Lancet.

[21]  C. Lugowski,et al.  Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. , 1981, Journal of immunology.

[22]  E. C. Beuvery.  Immunisation against bacterial meningitis. , 1981, The Journal of infection.

[23]  S. Sarna,et al.  Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. , 1980, The Journal of infectious diseases.

[24]  E. Gotschlich,et al.  Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. , 1977, Pediatrics.

[25]  S. Sarna,et al.  Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. , 1977, The New England journal of medicine.

[26]  E. Gotschlich,et al.  Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis. , 1977, The Journal of infectious diseases.

[27]  P. Mäkelä,et al.  EFFECT OF GROUP-A MENINGOCOCCAL VACCINE IN ARMY RECRUITS IN FINLAND , 1975, The Lancet.

[28]  M. Artenstein,et al.  HUMAN IMMUNITY TO THE MENINGOCOCCUS IV. IMMUNOGENICITY OF GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDES IN HUMAN VOLUNTEERS , 1969 .

[29]  M. Artenstein,et al.  HUMAN IMMUNITY TO THE MENINGOCOCCUS : III. PREPARATION AND IMMUNOCHEMICAL PROPERTIES OF THE GROUP A, GROUP B, AND GROUP C MENINGOCOCCAL POLYSACCHARIDES , 1969 .

[30]  J. Eskola,et al.  Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. , 1998, Vaccine.

[31]  S. Jaffar,et al.  Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. , 1997, The Journal of infectious diseases.

[32]  D. Crook,et al.  The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. , 1995, The Journal of infectious diseases.